Browse by UCL people
Group by: Type | Date
Number of items: 13.
Article
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylation.
[Corrigendum].
Nature Communications
, 9
, Article 4642. 10.1038/s41467-018-07155-4.
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Pan-cancer deconvolution of tumour composition using DNA methylation.
Nature Communications
, 9
, Article 3220. 10.1038/s41467-018-05570-1.
|
Ghorani, E;
Kaur, B;
Fisher, RA;
Short, D;
Joneborg, U;
Carlson, JW;
Akarca, A;
... Seckl, MJ; + view all
(2017)
Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia.
The Lancet
, 390
(10110)
pp. 2343-2345.
10.1016/S0140-6736(17)32894-5.
|
Ghorani, E;
Quezada, SA;
(2018)
Chromatin regulation and immune escape.
Science
, 359
(6377)
pp. 745-746.
10.1126/science.aat0383.
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
Ghorani, E;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Lynch, M;
Peggs, KS;
Swanton, C;
(2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Annals of Oncology
, 29
(1)
pp. 271-279.
10.1093/annonc/mdx687.
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
Lakins, MA;
Ghorani, E;
Munir, H;
Martins, CP;
Shields, JD;
(2018)
Cancer-associated fibroblasts induce antigen-specific deletion of CD8+T Cells to protect tumour cells.
Nat Commun
, 9
, Article 948. 10.1038/s41467-018-03347-0.
|
Menares, E;
Gálvez-Cancino, F;
Cáceres-Morgado, P;
Ghorani, E;
López, E;
Díaz, X;
Saavedra-Almarza, J;
... Lladser, A; + view all
(2019)
Tissue-resident memory CD8⁺ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
Nature Communications
, 10
(1)
, Article 4401. 10.1038/s41467-019-12319-x.
|
Solomon, I;
Amann, M;
Goubier, A;
Vargas, FA;
Zervas, D;
Qing, C;
Henry, JY;
... Quezada, SA; + view all
(2020)
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity.
Nature Cancer
, 1
(12)
pp. 1153-1166.
10.1038/s43018-020-00133-0.
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
Thesis
|
Ghorani, Ehsan;
(2022)
Intratumour CD4 T cell differentiation skewing and loss of immune fitness in non-small cell lung cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|